Back to News
Market Impact: 0.48
Aethlon Medical Shares Surge Over 470% On North Immunology Merger, $180M Financing
Source: Nasdaq
M&A & RestructuringPrivate Markets & VentureHealthcare & BiotechCompany Fundamentals
Aethlon Medical shares surged more than 470% after announcing a definitive all-stock merger with North Immunology and an oversubscribed $180 million private placement. The financing materially strengthens the combined company's capital position, while the transaction is a significant strategic event for Aethlon's biotechnology business.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.82
Ticker Sentiment
AEMD0.95
More News
- Nasdaq Jumps 400 Points; US Weekly Jobless Claims Fall
- California AG Says Paramount-WBD Merger Would Hurt the State
- This AI-picked stock jumps 18% on Amazon’s $8 billion power deal
- US to Sell F-35s to Saudi Arabia in $24.3 Billion Deal
- California AG Bonta on Paramount-Warner Bros., Meta and AI
- Crusoe raises $3.9B to build massive data centers and small modular “AI factories”